Federal contract award

75F40124F80296

AB ASSURANCE SERVICE PLANS ON ABI 7500 FAST RT PCR INSTRUMENTS

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS334516 — Analytical Laboratory Instrument Manufacturing
PSCJ066 — Maintenance, Repair and Rebuilding of Equipment: Instruments and Laboratory Equipment
Parent award / vehicleGS07F0636W
Set-asideNot reported
Pricing typeFIRM FIXED PRICE
Obligations$96.6K
Current contract value$96.6K
Potential contract value / ceiling$96.6K
Start dateSep 17, 2024
Current end dateSep 17, 2027
Potential end dateSep 17, 2027
Latest award activitySep 9, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Sep 9, 2026P00002$33.2KAB ASSURANCE SERVICE PLANS ON ABI 7500 FAST RT PCR INSTRUMENTS
Sep 4, 2025P00001$31.6KAB ASSURANCE SERVICE PLANS ON ABI 7500 FAST RT PCR INSTRUMENTS
Sep 17, 20240$31.8KAB ASSURANCE SERVICE PLANS ON ABI 7500 FAST RT PCR INSTRUMENTS

Estimated positioning window

Oct 25, 2026 – Mar 17, 2027

Modeled likelihood: 70%. These are AcornBids estimates, not confirmed solicitation dates.

{
  "psc": "J066",
  "naics": "334516",
  "agency": "Department of Health and Human Services",
  "office": "FDA OFFICE OF ACQ  GRANT SVCS",
  "vehicle": "GS07F0636W",
  "incumbent": "FRANKLIN YOUNG INTERNATIONAL, INCORPORATED",
  "known_forecast": false,
  "option_end_date": "2027-09-17",
  "contract_end_date": "2027-09-17",
  "latest_action_date": "2026-09-09",
  "modification_count": 3,
  "historical_award_count": 101,
  "historical_cadence_days": 49
}

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.